Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Medical Device Collaboration and Licensing Deals Report 2016-2026, Featuring AliveCor, Boston Scientific, CardieX, Zimmer Biomet, Garmin and Many More

globenewswire.com
BSX Boston Scientific is listed as a company featured in a report about medical device collaboration and licensing deals. The article itself does not offer a specific sentiment or analysis of the company. ZBH Zimmer Biomet is named as a company included in the scope of the medical device collaboration and licensing deals report. The article does not provide any sentiment or analysis regarding the company. GPC Garmin is listed as a company featured in the medical device collaboration and licensing deals report. The article does not offer any specific sentiment or analysis for Garmin.

Medical Device Collaboration and Licensing Deals Report 2016-2026, Featuring AliveCor, Boston Scientific, CardieX, Zimmer Biomet, Garmin and Many More Dublin, July 22, 2026 (GLOBE NEWSWIRE) -- The "Medical Device Collaboration and Licensing Deals 2016-2026" has been added to ResearchAndMarkets.com's offering.

This report provides a comprehensive and structured analysis of 1000+ medical device collaboration and licensing deals, delivering a clear and evidence-based view of how partnerships are designed, negotiated, and executed across the market.

The definitive benchmark for medical device dealmaking

Medical device partnering is driven by hardware innovation, engineering expertise, and clinical application, with deal structures reflecting product development cycles, regulatory pathways, and integration into healthcare systems.

Establish a clear view of market standards

The report enables a precise understanding of how medical device deals are structured in practice, allowing you to:

Beyond headline deal data, the report provides access to underlying contract documents, enabling a detailed understanding of how agreements are constructed in practice.

This includes:

This level of transparency is critical to understanding how value, risk, and control are allocated within medical device partnerships, particularly where regulatory approval, product lifecycle management, and clinical adoption are key considerations.

Designed for real-world BD and strategy use

The report is widely used to:

What's included?

Combining comprehensive deal coverage with contract-level insight, this report provides a trusted, evidence-based reference for how medical device partnerships are structured, negotiated, and valued.

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/hixs5n

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.